scholarly article | Q13442814 |
P50 | author | Mel Krajden | Q6810759 |
Naveed Zafar Janjua | Q39716263 | ||
Salaheddin M. Mahmud | Q42242293 | ||
James A Dickinson | Q42422634 | ||
Yan Li | Q69032212 | ||
Nathalie Bastien | Q69032280 | ||
Hugues Charest | Q86870110 | ||
Gaston De Serres | Q86870133 | ||
Jonathan B Gubbay | Q87716515 | ||
Danuta M. Skowronski | Q111259505 | ||
Suzana Sabaiduc | Q114718265 | ||
Martin Petric | Q114718266 | ||
Anne-Luise Winter | Q114718267 | ||
Kevin Fonseca | Q114718268 | ||
Paul Van Caeseele | Q114718272 | ||
Trijntje L Kwindt | Q114718277 | ||
P2860 | cites work | Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance | Q28728106 |
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. | Q30357784 | ||
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada | Q30388012 | ||
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. | Q30399334 | ||
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 | ||
Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children | Q30409092 | ||
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates | Q33554684 | ||
Serologic assays for influenza surveillance, diagnosis and vaccine evaluation | Q34194336 | ||
Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season | Q34614814 | ||
Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis | Q34783486 | ||
Recent changes among human influenza viruses | Q35784247 | ||
Variable efficacy of repeated annual influenza vaccination | Q36705674 | ||
Persistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season | Q36849805 | ||
Influenza vaccine effectiveness in the community and the household | Q36956943 | ||
Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? | Q37084793 | ||
Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons | Q42239081 | ||
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution | Q42253862 | ||
Influenza Β/Victoria antigen induces strong recall of Β/Yamagata but lower Β/Victoria response in children primed with two doses of Β/Yamagata | Q42613649 | ||
Kinetics of the antibody response to seasonal influenza vaccination among the elderly | Q43171479 | ||
Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons | Q43209729 | ||
Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants | Q45167252 | ||
Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required | Q45375388 | ||
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period | Q45760959 | ||
Understanding suboptimal influenza vaccine effectiveness within the agent, host, and environment paradigm. | Q45932844 | ||
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season | Q47843797 | ||
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. | Q48071872 | ||
Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. | Q50637887 | ||
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. | Q50801938 | ||
Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults | Q51152487 | ||
Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort | Q57384993 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vaccine | Q134808 |
P304 | page(s) | 126-137 | |
P577 | publication date | 2014-01-19 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine | |
P478 | volume | 210 |
Q47583920 | 2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children. |
Q40087098 | 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project. |
Q39322780 | A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control. |
Q38692107 | A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children. |
Q38671179 | A systematic review of the health economic consequences of quadrivalent influenza vaccination. |
Q41932798 | Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada |
Q35211657 | Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany |
Q50065275 | Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness |
Q47613621 | Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada |
Q47678684 | Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons |
Q30891396 | Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis |
Q92828089 | Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach |
Q39215322 | Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera |
Q53283393 | Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis. |
Q30401497 | Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus |
Q30391150 | Effect of Statin Use on Influenza Vaccine Effectiveness |
Q30403059 | Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain |
Q35758531 | Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results |
Q41932605 | Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies |
Q34451202 | Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies |
Q40015287 | Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons. |
Q58722425 | Estimating Vaccine-Driven Selection in Seasonal Influenza |
Q38660898 | Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines. |
Q37669436 | Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy. |
Q90186606 | Genetic evolution of influenza viruses among selected countries in Latin America, 2017-2018 |
Q64276594 | HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy |
Q54263414 | Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis. |
Q38408953 | Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14. |
Q59349308 | Immune History and Influenza Vaccine Effectiveness |
Q26744404 | Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials |
Q34393525 | Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons |
Q90108100 | Influenza B virus infections in Western Saxony, Germany in three consecutive seasons between 2015 and 2018: Analysis of molecular and clinical features |
Q30383312 | Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. |
Q37568360 | Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses |
Q47137946 | Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada |
Q39833076 | Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 - a rapid epidemiological and virological assessment |
Q34505958 | Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain |
Q35531934 | Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type |
Q38415770 | Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season |
Q54261205 | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. |
Q87852509 | Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18 |
Q42237299 | Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. |
Q41474318 | Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. |
Q42148972 | Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014. |
Q87601707 | Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: a comparative effectiveness study using the Valencia health care information system |
Q64126022 | Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment |
Q35130915 | Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses |
Q47413448 | Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. |
Q92498126 | Patterns of influenza B circulation in Latin America and the Caribbean, 2010-2017 |
Q36296560 | Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea |
Q39813068 | Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. |
Q47229285 | Potential impact of B lineage mismatch on trivalent influenza vaccine effectiveness during the 2015-2016 influenza season among nursery school children in Suzhou, China |
Q34778408 | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review |
Q36090140 | Prediction of influenza B vaccine effectiveness from sequence data |
Q40374569 | Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans |
Q97530377 | Quantifying the annual incidence and underestimation of seasonal influenza: A modelling approach |
Q40143693 | Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness. |
Q39340731 | Repeated annual influenza vaccination and vaccine effectiveness: review of evidence |
Q49400944 | Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study. |
Q57100141 | Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness? |
Q35225209 | Suboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult Korean populations |
Q36847186 | The Molecular Epidemiology and Evolutionary Dynamics of Influenza B Virus in Two Italian Regions during 2010-2015: The Experience of Sicily and Liguria |
Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Q34194443 | The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013. |
Q38639994 | The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis |
Q60912426 | The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis |
Q37010796 | Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study |
Q47160827 | Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada |
Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |
Search more.